Contrary to media reports, many states have flatly denied deaths due to oxygen shortage during the second wave of Covid-19. This is despite courts pulling them up for their lackadaisical attitude towards patients.
The Delhi High Court bench headed by Justice Vipin Sanghi observed, “…it has not been examined, as to how the Gautam Gambhir Foundation could have procured the drug Fabiflu from the license dealers/retailers between 22.04.2021 and 29.04.2021.”
The task force interim report on Delhi further said that there was gross discrepancy in the actual oxygen use claimed and the calculation of consumption using bed capacity. It further said that the discrepancy in data was because of “a poor understanding of demand calculation”.
Retired telecom chief engineer moves HC seeking to know if the Delhi government is prepared to face challenges posed by the Covid-19 third wave which has been forecast by experts. India has performed miserably in the second wave particularly in the area of hospital beds and oxygen availability.
Supreme Court insists on making a plan to protect children from the third wave also suggested keeping buffer stock. Center said, there is a shortage in the Delhi government's plan, oxygen is not getting to the needy.